TheFly.com
BMRN
BioMarin
$
()
BioMarin participates in a conference call with JPMorgan.
BioMarin participates in a conference call with JPMorgan.
BioMarin participates in a conference call with JPMorgan.
BioMarin presents new data for Voxzogo in achondroplasia and achondroplasia
BioMarin exec Fuchs sells 35,341 common shares
BioMarin appoints Cristin Hubbard as Chief Commercial Officer
BioMarin discloses receipt of subpoena from U.S. Department of Justice
BioMarin price target lowered by $8 at Piper Sandler, here's why
BioMarin price target lowered by $20 at BofA, here's why
BioMarin sees 2024 non-GAAP EPS $2.60-$2.80, consensus $1.96
BioMarin reports Q4 non-GAAP EPS 49c, consensus 23c
BioMarin a 'favorite' name in Biotech, says Cantor Fitzgerald
BioMarin to present positive data on Roctavian durability at EAHAD Congress
Copyright ©1998-2024 Thefly.com LLC
